Just when I thought the BIND debate was finished Chris Hogue responds to a previous attack with "The other side of staying out of BIND" published recently in Nature Biotechnology.
Personally, I think both sides have a point. Busa's being that we can't fund multi million projects without reasonable returns, and Hogue's that long term funding of databases, such as BIND, is needed.
No matter what side of the debate you fall on you have to appreciate the academic mud slinging from both parties.
Is this my equivalent of reading tabloids about OJ or Paris?